Covered recipient · General Payments record
ROBERT E RANNEY
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$6,912.04
- Reported across 330 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $255.39 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $119.25 | 5 |
| Novo Nordisk AS | $49.59 | 2 |
| GlaxoSmithKline, LLC. | $37.63 | 2 |
| Merck Sharp & Dohme Corporation | $34.00 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $14.92 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| GlaxoSmithKline, LLC. | $23.86 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116559838 | CMS |
| GlaxoSmithKline, LLC. | $13.77 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116229835 | CMS |
| Lilly USA, LLC | $29.75 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135367584 | CMS |
| Lilly USA, LLC | $21.10 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135367580 | CMS |
| Lilly USA, LLC | $22.72 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135369210 | CMS |
| Lilly USA, LLC | $22.91 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135367582 | CMS |
| Lilly USA, LLC | $22.77 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135358758 | CMS |
| Merck Sharp & Dohme LLC | $34.00 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141659879 | CMS |
| Novartis Pharmaceuticals Corporation | $14.92 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087340253 | CMS |
| Novo Nordisk Inc | $25.00 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097471113 | CMS |
| Novo Nordisk Inc | $24.59 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096661124 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.